# Effects of cancer-induced cachexia and administration of l-glutathione on the intestinal mucosa in rat

**Authors:** Sabrina Silva Sestak, Fabiana Galvão da Motta Lima, Ana Paula de Oliveira, Letícia Ganem Rillo Paz Barateiro, Flávia Cristina Vieira-Frez, Sara Raquel Garcia de Souza, Flávia Alessandra Guarnier, Juliana Vanessa Colombo Martins Perles, Jacqueline Nelisis Zanoni

PMC · DOI: 10.1007/s00726-024-03391-9 · 2024-04-12

## TL;DR

This study examines how cancer-induced cachexia affects rat intestinal mucosa and whether l-glutathione can mitigate some of the damage.

## Contribution

The study introduces new insights into the protective effects of l-glutathione on intestinal mucosa in cancer-induced cachexia.

## Key findings

- Cancer-induced cachexia caused mucosal atrophy and reduced cell proliferation in rat intestines.
- l-Glutathione reduced apoptosis and mast cell recruitment, partially reversing mucosal damage.
- l-Glutathione did not reverse cachexia-related reductions in 5-HT-IR cells or VIPergic varicosities.

## Abstract

Walker-256 tumor is an experimental model known to promote cachexia syndrome, oxidative stress, and systemic inflammation. This study evaluated the duodenal mucosa of rats with Walker-256 tumor administered with 1% l-glutathione, intending to evaluate the damage caused by cancer-associated cachexia in the gastrointestinal tract and the effects of antioxidant administration on mucosal protection. Twenty-four 55-day-old male Wistar rats were distributed into four groups: control (C); control administered with 1% l-glutathione (C-GSH); Walker-256 tumor (W) and Walker-256 tumor administered with 1% l-glutathione (W-GSH). After 14 days of treatment, the duodenum was harvested for morphometric analysis of the mucosa, proliferation, apoptosis, immunostaining of varicosities immunoreactive (IR) to vasoactive intestinal peptide (VIP) and 5-HT-IR cells, and quantification of mast cells and goblet cells. Walker-256 tumor-bearing rats showed cachexia syndrome, mucosal atrophy, reduced cell proliferation, reduced 5-HT-IR cells, and increased goblet cells and VIPergic varicosities, which were not reversed by l-glutathione. On the other hand, l-glutathione caused a reduction of cells in apoptosis and mast cell recruitment, demonstrating a partial recovery of the damage detected in the intestinal mucosa.

## Linked entities

- **Proteins:** VIP (vasoactive intestinal peptide)
- **Chemicals:** l-glutathione (PubChem CID 65359)

## Full-text entities

- **Genes:** Vip (vasoactive intestinal peptide) [NCBI Gene 117064] {aka vip/phi27}
- **Diseases:** cancer (MESH:D009369), cachexia (MESH:D002100), inflammation (MESH:D007249), Walker-256 tumor (MESH:D002279), atrophy (MESH:D001284)
- **Chemicals:** 5-HT (MESH:D012701), GSH (MESH:D005978)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** Walker-256 tumor — Rattus norvegicus (Rat), Adenocarcinoma of the rat mammary gland, Cancer cell line (CVCL_3537)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11009745/full.md

---
Source: https://tomesphere.com/paper/PMC11009745